These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33612802)

  • 1. Investigative study on the role of the Toxo 5699 gene in the Toxoplasma gondii lytic cycle using the CRISPR/Cas9 system.
    De Silva JR; Ching XT; Lau YL
    Trop Biomed; 2020 Jun; 37(2):324-332. PubMed ID: 33612802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii.
    Shen B; Brown K; Long S; Sibley LD
    Methods Mol Biol; 2017; 1498():79-103. PubMed ID: 27709570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9.
    Shen B; Brown KM; Lee TD; Sibley LD
    mBio; 2014 May; 5(3):e01114-14. PubMed ID: 24825012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the basic functions of six calcium-dependent protein kinases in Toxoplasma gondii using CRISPR-Cas9 system.
    Wang JL; Huang SY; Li TT; Chen K; Ning HR; Zhu XQ
    Parasitol Res; 2016 Feb; 115(2):697-702. PubMed ID: 26499803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing Systems for Cas9 Expression in Toxoplasma gondii.
    Markus BM; Bell GW; Lorenzi HA; Lourido S
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31243081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii.
    Shen B; Powell RH; Behnke MS
    J Vis Exp; 2017 Jun; (124):. PubMed ID: 28671645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasma CRISPR/Cas9 constructs are functional for gene disruption in Neospora caninum.
    Arranz-Solís D; Regidor-Cerrillo J; Lourido S; Ortega-Mora LM; Saeij JPJ
    Int J Parasitol; 2018 Jul; 48(8):597-600. PubMed ID: 29625127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Characterization of 15 Novel Dense Granule Proteins in Toxoplasma gondii Using the CRISPR-Cas9 System.
    Zheng XN; Wang JL; Elsheikha HM; Wang M; Zhang ZW; Sun LX; Wang XC; Zhu XQ; Li TT
    Microbiol Spectr; 2023 Feb; 11(1):e0307822. PubMed ID: 36515555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single- and duplex TaqMan-quantitative PCR for determining the copy numbers of integrated selection markers during site-specific mutagenesis in Toxoplasma gondii by CRISPR-Cas9.
    Hänggeli KPA; Hemphill A; Müller N; Schimanski B; Olias P; Müller J; Boubaker G
    PLoS One; 2022; 17(9):e0271011. PubMed ID: 36112587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of strain-specific phenotypes associated with knockout of dense granule protein 9 in Toxoplasma gondii.
    Guo H; Gao Y; Jia H; Moumouni PFA; Masatani T; Liu M; Lee SH; Galon EM; Li J; Li Y; Tumwebaze MA; Benedicto B; Xuan X
    Mol Biochem Parasitol; 2019 Apr; 229():53-61. PubMed ID: 30849416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Characterization of Dense Granule Proteins in
    Bai MJ; Wang JL; Elsheikha HM; Liang QL; Chen K; Nie LB; Zhu XQ
    Front Cell Infect Microbiol; 2018; 8():300. PubMed ID: 30211128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient genome engineering of Toxoplasma gondii using CRISPR/Cas9.
    Sidik SM; Hackett CG; Tran F; Westwood NJ; Lourido S
    PLoS One; 2014; 9(6):e100450. PubMed ID: 24971596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
    Markus BM; Boydston EA; Lourido S
    mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9-based genome-wide screening of Toxoplasma gondii.
    Sidik SM; Huet D; Lourido S
    Nat Protoc; 2018 Jan; 13(1):307-323. PubMed ID: 29323662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CRISPR platform for targeted in vivo screens identifies Toxoplasma gondii virulence factors in mice.
    Young J; Dominicus C; Wagener J; Butterworth S; Ye X; Kelly G; Ordan M; Saunders B; Instrell R; Howell M; Stewart A; Treeck M
    Nat Commun; 2019 Sep; 10(1):3963. PubMed ID: 31481656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Noncanonical Calcium-Dependent Protein Kinases in Toxoplasma gondii by Targeted Gene Deletion Using CRISPR/Cas9.
    Long S; Wang Q; Sibley LD
    Infect Immun; 2016 May; 84(5):1262-1273. PubMed ID: 26755159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a CRISPR/Cas9 system in Entamoeba histolytica: proof of concept.
    Kangussu-Marcolino MM; Morgado P; Manna D; Yee H; Singh U
    Int J Parasitol; 2021 Feb; 51(2-3):193-200. PubMed ID: 33264648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of transposase on the transposition activity of piggyBac transposon transfected into Toxoplasma gondii].
    Song XS; Wei F; Zhang YG; Cao LL; Liu Q
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):244-5. PubMed ID: 24812869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-Mediated Generation of Tetracycline Repressor-Based Inducible Knockdown in Toxoplasma gondii.
    Jacot D; Soldati-Favre D
    Methods Mol Biol; 2020; 2071():125-141. PubMed ID: 31758450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockout of leucine aminopeptidase in Toxoplasma gondii using CRISPR/Cas9.
    Zheng J; Jia H; Zheng Y
    Int J Parasitol; 2015 Feb; 45(2-3):141-8. PubMed ID: 25444863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.